MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

Co-Diagnostics Inc

Slēgts

SektorsVeselības aprūpe

0.28 3.7

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.23

Max

0.28

Galvenie mērījumi

By Trading Economics

Ienākumi

3.5M

-7.5M

Pārdošana

-99K

50K

Peļņas marža

-14,983.533

Darbinieki

132

EBITDA

4.3M

-7.2M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+284.62% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 7. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-2.7M

8.8M

Iepriekšējā atvēršanas cena

-3.42

Iepriekšējā slēgšanas cena

0.28

Ziņu noskaņojums

By Acuity

50%

50%

157 / 376 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Co-Diagnostics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 9. jūl. 15:46 UTC

Galvenie tirgus virzītāji

BitMine Shares Fall After Closing of $250 Million Private Placement

2025. g. 9. jūl. 23:44 UTC

Tirgus saruna

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

2025. g. 9. jūl. 23:42 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 9. jūl. 23:42 UTC

Tirgus saruna

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

2025. g. 9. jūl. 22:59 UTC

Tirgus saruna

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

2025. g. 9. jūl. 22:59 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 9. jūl. 20:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2025. g. 9. jūl. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 9. jūl. 20:26 UTC

Peļņas

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

2025. g. 9. jūl. 19:18 UTC

Tirgus saruna

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

2025. g. 9. jūl. 19:03 UTC

Tirgus saruna

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

2025. g. 9. jūl. 18:31 UTC

Tirgus saruna

Some Fed Officials Supported Considering July Cut -- Market Talk

2025. g. 9. jūl. 17:07 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

2025. g. 9. jūl. 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk -2-

2025. g. 9. jūl. 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 9. jūl. 16:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2025. g. 9. jūl. 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 9. jūl. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 9. jūl. 16:14 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 9. jūl. 16:14 UTC

Tirgus saruna

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

2025. g. 9. jūl. 16:14 UTC

Iegādes, apvienošanās, pārņemšana

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

2025. g. 9. jūl. 16:12 UTC

Tirgus saruna

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

2025. g. 9. jūl. 16:08 UTC

Tirgus saruna

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

2025. g. 9. jūl. 15:31 UTC

Galvenie tirgus virzītāji

BitMine Shares Fall After Closing of $250M Private Placement

2025. g. 9. jūl. 15:31 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

2025. g. 9. jūl. 15:27 UTC

Tirgus saruna

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

2025. g. 9. jūl. 14:36 UTC

Iegādes, apvienošanās, pārņemšana

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

2025. g. 9. jūl. 14:31 UTC

Iegādes, apvienošanās, pārņemšana

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

2025. g. 9. jūl. 14:26 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 9. jūl. 14:26 UTC

Tirgus saruna

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Salīdzinājums

Cenas izmaiņa

Co-Diagnostics Inc Prognoze

Cenas mērķis

By TipRanks

284.62% augšup

Prognoze 12 mēnešiem

Vidējais 1 USD  284.62%

Augstākais 1 USD

Zemākais 1 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Co-Diagnostics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

0

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.3495 / 0.3699Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

157 / 376 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.